The novel AQP9 inhibitor RG100204 showed reduced septic cardiomyopathy and multi-organ failure in a murine CLP model of polymicrobial sepsis by improving outcomes like hypothermia and renal and cardiac dysfunction [275]. Here, AQP9 is linked to Sepsis.